688136 科兴制药
已收盘 12-09 15:00:01
资讯
新帖
简况
科兴制药(688136.SH)：眼科制剂GB10注射液获得药物临床试验批准
智通财经 · 12-08 18:55
科兴制药(688136.SH)：眼科制剂GB10注射液获得药物临床试验批准
科兴制药（688136）披露以集中竞价交易方式回购公司股份的进展公告，12月02日股价下跌1.95%
证券之星 · 12-02
科兴制药（688136）披露以集中竞价交易方式回购公司股份的进展公告，12月02日股价下跌1.95%
科兴制药（688136）披露股东询价转让结果暨持股5%以上股东权益变动触及5%整数倍提示，11月20日股价上涨0.6%
证券之星 · 11-20
科兴制药（688136）披露股东询价转让结果暨持股5%以上股东权益变动触及5%整数倍提示，11月20日股价上涨0.6%
科兴制药（688136）披露股东询价转让定价情况提示性公告，11月18日股价下跌0.4%
证券之星 · 11-18
科兴制药（688136）披露股东询价转让定价情况提示性公告，11月18日股价下跌0.4%
科兴制药(688136.SH)：科益医药拟询价转让5%公司股份
智通财经 · 11-14
科兴制药(688136.SH)：科益医药拟询价转让5%公司股份
每周股票复盘：科兴制药（688136）H股上市申请已递交
证券之星 · 11-09
每周股票复盘：科兴制药（688136）H股上市申请已递交
科兴制药(688136.SH)向香港联交所递交H股发行上市申请并刊发申请资料
智通财经 · 11-06
科兴制药(688136.SH)向香港联交所递交H股发行上市申请并刊发申请资料
科兴生物制药股份有限公司向港交所递交上市申请
老虎资讯综合 · 11-06
科兴生物制药股份有限公司向港交所递交上市申请
科兴制药（688136）披露以集中竞价交易方式回购公司股份的进展公告，11月03日股价下跌2.08%
证券之星 · 11-03
科兴制药（688136）披露以集中竞价交易方式回购公司股份的进展公告，11月03日股价下跌2.08%
每周股票复盘：科兴制药（688136）股东户数增25.03%，净利同比升547.7%
证券之星 · 11-02
每周股票复盘：科兴制药（688136）股东户数增25.03%，净利同比升547.7%
科兴制药(688136)9月30日股东户数1.18万户，较上期增加25.03%
证券之星 · 10-30
科兴制药(688136)9月30日股东户数1.18万户，较上期增加25.03%
图解科兴制药三季报：第三季度单季净利润同比增长483.27%
证券之星 · 10-29
图解科兴制药三季报：第三季度单季净利润同比增长483.27%
众生药业：已与科兴制药达成昂拉地韦片澳门商业化合作
证券之星 · 10-24
众生药业：已与科兴制药达成昂拉地韦片澳门商业化合作
每周股票复盘：科兴制药（688136）拟发行H股并在港交所上市
证券之星 · 10-19
每周股票复盘：科兴制药（688136）拟发行H股并在港交所上市
科兴制药（688136）披露拟发行H股并在港交所上市，10月17日股价下跌4.12%
证券之星 · 10-17
科兴制药（688136）披露拟发行H股并在港交所上市，10月17日股价下跌4.12%
10月17日科兴制药创60日新低，中航优选领航混合发起A基金重仓该股
证券之星 · 10-17
10月17日科兴制药创60日新低，中航优选领航混合发起A基金重仓该股
每周股票复盘：科兴制药（688136）拟发行H股募资研发
证券之星 · 10-12
每周股票复盘：科兴制药（688136）拟发行H股募资研发
科兴制药（688136）披露拟发行H股并在港交所上市，10月9日股价下跌0.54%
证券之星 · 10-09
科兴制药（688136）披露拟发行H股并在港交所上市，10月9日股价下跌0.54%
科兴制药(688136.SH)筹划发行H股股票并在香港联交所上市
智通财经 · 09-30
科兴制药(688136.SH)筹划发行H股股票并在香港联交所上市
科兴制药(688136.SH)：GB10注射液临床试验注册申请获得受理
智通财经 · 09-29
科兴制药(688136.SH)：GB10注射液临床试验注册申请获得受理
公司概况
公司名称：
科兴生物制药股份有限公司
所属行业：
医药制造业
上市日期：
2020-12-14
主营业务：
科兴生物制药股份有限公司的主营业务是重组蛋白药物和微生态制剂的研发、生产、销售。公司的主要产品是依普定、赛若金、白特喜、常乐康。
发行价格：
22.33
{"stockData":{"symbol":"688136","market":"SH","secType":"STK","nameCN":"科兴制药","latestPrice":32.67,"timestamp":1765263601000,"preClose":32.82,"halted":0,"volume":1085016,"delay":0,"changeRate":-0.0046,"floatShares":200999999,"shares":200999999,"eps":0.624,"marketStatus":"已收盘","change":-0.15,"latestTime":"12-09 15:00:01","open":32.83,"high":33.16,"low":32.4,"amount":35532100,"amplitude":0.0232,"askPrice":32.67,"askSize":20,"bidPrice":32.66,"bidSize":3,"shortable":0,"etf":0,"ttmEps":0.624,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765330200000},"marketStatusCode":5,"adr":0,"adjPreClose":32.82,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765243800000,1765251000000],[1765256400000,1765263600000]],"highLimit":36.1,"lowLimit":29.54,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":201257250,"isCdr":false,"pbRate":3.84,"roa":"--","peRate":52.355769,"roe":"6.66%","epsLYR":0.16,"committee":-0.20678,"marketValue":6575000000,"turnoverRate":0.0054,"status":1,"afterMarket":{"amount":0,"volume":0,"close":32.67,"buyVolume":0,"sellVolume":663,"time":1765265637768,"indexStatus":"已收盘 12-09 15:30:00","preClose":32.82},"floatMarketCap":6575000000},"requestUrl":"/m/hq/s/688136/wiki","defaultTab":"wiki","newsList":[{"id":"2589346843","title":"科兴制药(688136.SH)：眼科制剂GB10注射液获得药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2589346843","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589346843?lang=zh_cn&edition=full","pubTime":"2025-12-08 18:55","pubTimestamp":1765191340,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科兴制药 发布公告，近日，公司全资子公司深圳科兴药业有限公司收到国家药品监督管理局签发的《药物临床试验批准通知书》，国家药监局批准同意深圳科兴开展“GB10注射液”的临床试验。GB10注射液是深圳科兴自主研发、拥有全球知识产权的抗VEGF/Ang-2双靶点抗体高浓度眼科专用蛋白药物制剂。GB10注射液浓度达到140mg/mL，可减少注射体积或提高给药量，延长给药周期，预期实现每4个月给药一次，极大提高患者依从性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科兴制药(688136.SH)：眼科制剂GB10注射液获得药物临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2588051892","title":"科兴制药（688136）披露以集中竞价交易方式回购公司股份的进展公告，12月02日股价下跌1.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588051892","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588051892?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:29","pubTimestamp":1764685746,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，科兴制药报收于32.63元，较前一交易日下跌1.95%，最新总市值为65.67亿元。近日，科兴制药发布关于以集中竞价交易方式回购公司股份的进展公告。公告显示，截至2025年11月30日，公司通过集中竞价交易方式累计回购股份1,319,333股，占公司总股本的0.66%，已支付资金总额4,924.18万元，回购价格区间为23.14元/股至43.50元/股。本次回购股份拟用于员工持股计划或股权激励，回购期限为2025年3月17日至2026年3月16日，预计回购金额为3,000万元至6,000万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200040001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2584309031","title":"科兴制药（688136）披露股东询价转让结果暨持股5%以上股东权益变动触及5%整数倍提示，11月20日股价上涨0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584309031","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584309031?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:27","pubTimestamp":1763648842,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘，科兴制药报收于33.7元，较前一交易日上涨0.6%，最新总市值为67.82亿元。近日，科兴制药发布《股东询价转让结果报告书暨持股5%以上股东权益变动触及5%整数倍的提示性公告》。本次转让后，科益医药及其一致行动人邓学勤合计持股比例由55.38%降至50.38%，触及5%整数倍。转让方为公司控股股东，本次转让不会导致公司控制权变更。中国国际金融股份有限公司对本次转让出具核查意见，确认转让过程合法合规。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000038341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2584933913","title":"科兴制药（688136）披露股东询价转让定价情况提示性公告，11月18日股价下跌0.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584933913","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584933913?lang=zh_cn&edition=full","pubTime":"2025-11-18 17:57","pubTimestamp":1763459841,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，科兴制药报收于34.45元，较前一交易日下跌0.4%，最新总市值为69.33亿元。该股当日开盘34.4元，最高34.85元，最低34.18元，成交额达6579.93万元，换手率为0.95%。公司于近日发布股东询价转让定价情况提示性公告。参与报价及申购的机构投资者共24家，有效认购股份数量为14,877,000股，有效认购倍数为1.48倍。本次询价转让拟转让股份已获全额认购，初步确定受让方为12家机构投资者，拟受让股份总数为10,062,800股。本次转让不涉及公司控制权变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800027791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2583503742","title":"科兴制药(688136.SH)：科益医药拟询价转让5%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2583503742","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583503742?lang=zh_cn&edition=full","pubTime":"2025-11-14 20:15","pubTimestamp":1763122501,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科兴制药(688136.SH)披露股东询价转让计划书，本次拟参与本次询价转让的股东为科益医药，拟转让股份的总数为1006.28万股，占公司总股本的比例为5%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369553.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688136","BK1574","BK1515","09939","159938","BK0239","BK1161"],"gpt_icon":0},{"id":"2582861110","title":"每周股票复盘：科兴制药（688136）H股上市申请已递交","url":"https://stock-news.laohu8.com/highlight/detail?id=2582861110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582861110?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:00","pubTimestamp":1762632025,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，科兴制药报收于36.89元，较上周的41.3元下跌10.68%。本周，科兴制药11月3日盘中最高价报41.4元。本周关注点公司公告汇总：科兴制药已向香港联交所递交H股发行上市申请。关于向香港联交所递交H股发行上市申请并刊发申请资料的公告科兴生物制药股份有限公司已于2025年11月6日向香港联合交易所有限公司递交发行H股股票并在香港联交所主板上市的申请，并于同日在香港联交所网站刊登相关申请材料。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2581066824","title":"科兴制药(688136.SH)向香港联交所递交H股发行上市申请并刊发申请资料","url":"https://stock-news.laohu8.com/highlight/detail?id=2581066824","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581066824?lang=zh_cn&edition=full","pubTime":"2025-11-06 19:02","pubTimestamp":1762426966,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科兴制药(688136.SH)发布公告，公司已于2025年11月6日向香港联合交易所有限公司(简称“香港联交所”)递交了发行H股股票并在香港联交所主板挂牌上市的申请，并于同日在香港联交所网站刊登了本次发行上市的申请材料。该申请材料为公司按照香港证券及期货事务监察委员会(简称“香港证监会”)及香港联交所的要求编制和刊发，为草拟版本，其所载资料可能会适时作出更新及修订，投资者不应根据其中的资料作出任何投资决定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"1199358645","title":"科兴生物制药股份有限公司向港交所递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1199358645","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199358645?lang=zh_cn&edition=full","pubTime":"2025-11-06 18:48","pubTimestamp":1762426101,"startTime":"0","endTime":"0","summary":"11月6日，据港交所文件：科兴生物制药股份有限公司在港交所递交上市申请，独家保荐人为中信建投国际。","market":"hk","thumbnail":"https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688136"],"gpt_icon":0},{"id":"2580321490","title":"科兴制药（688136）披露以集中竞价交易方式回购公司股份的进展公告，11月03日股价下跌2.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580321490","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580321490?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:41","pubTimestamp":1762180879,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘，科兴制药报收于40.44元，较前一交易日下跌2.08%，最新总市值为81.39亿元。根据公司近日发布的公告，科兴生物制药股份有限公司就以集中竞价交易方式回购公司股份的进展进行了披露。公告显示，公司于2025年3月17日召开董事会审议通过回购股份方案，拟使用自有资金及专项贷款3,000万元至6,000万元，通过集中竞价交易方式回购股份，用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300036320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2580475670","title":"每周股票复盘：科兴制药（688136）股东户数增25.03%，净利同比升547.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580475670","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580475670?lang=zh_cn&edition=full","pubTime":"2025-11-02 02:52","pubTimestamp":1762023133,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，科兴制药报收于41.3元，较上周的37.11元上涨11.29%。本周，科兴制药10月31日盘中最高价报41.5元。科兴制药当前最新总市值83.12亿元，在生物制品板块市值排名36/51，在两市A股市值排名2215/5163。业绩披露要点：2025年前三季度归母净利润1.11亿元，同比上升547.7%。股本股东变化截至2025年9月30日，公司股东户数为1.18万户，较6月30日增加2356.0户，增幅25.03%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200000477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2579911860","title":"科兴制药(688136)9月30日股东户数1.18万户，较上期增加25.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579911860","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579911860?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:27","pubTimestamp":1761816476,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科兴制药披露，截至2025年9月30日公司股东户数为1.18万户，较6月30日增加2356.0户，增幅为25.03%。在生物制品行业个股中，科兴制药股东户数低于行业平均水平，截至9月30日，生物制品行业平均股东户数为3.41万户。从股价来看，2025年6月30日至2025年9月30日，科兴制药区间涨幅为2.09%，在此期间股东户数增加2356.0户，增幅为25.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000033098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2579943903","title":"图解科兴制药三季报：第三季度单季净利润同比增长483.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579943903","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579943903?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:09","pubTimestamp":1761739784,"startTime":"0","endTime":"0","summary":"证券之星消息，科兴制药2025年三季报显示，前三季度公司主营收入11.48亿元，同比上升10.54%；归母净利润1.11亿元，同比上升547.7%；扣非净利润7044.66万元，同比上升190.65%；其中2025年第三季度，公司单季度主营收入4.47亿元，同比上升60.65%；单季度归母净利润3091.85万元，同比上升483.27%；单季度扣非净利润2516.75万元，同比上升829.53%；负债率49.69%，投资收益2718.72万元，财务费用2315.98万元，毛利率63.54%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900041202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136"],"gpt_icon":0},{"id":"2577560462","title":"众生药业：已与科兴制药达成昂拉地韦片澳门商业化合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2577560462","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577560462?lang=zh_cn&edition=full","pubTime":"2025-10-24 15:39","pubTimestamp":1761291545,"startTime":"0","endTime":"0","summary":"证券之星消息，众生药业10月24日在投资者关系平台上答复投资者关心的问题。公司重视药品的国外市场机会，目前已与科兴制药达成昂拉地韦片在中国澳门地区的商业化合作，借助区域落地形成品牌海外辐射效应，助力公司完善国际化布局，为海外拓展积累经验。公司将适时开展昂拉地韦片海外市场的拓展，探索更多可能性，加快国际化推进步伐。公司密切关注疾病动态情况，积极做好药品生产和销售工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400023236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002317","BK0188","BK0077","688136"],"gpt_icon":0},{"id":"2576904626","title":"每周股票复盘：科兴制药（688136）拟发行H股并在港交所上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2576904626","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576904626?lang=zh_cn&edition=full","pubTime":"2025-10-19 03:04","pubTimestamp":1760814251,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，科兴制药报收于37.02元，较上周的39.6元下跌6.52%。本周关注点公司公告汇总：科兴制药拟发行H股并在香港联合交易所上市。公司公告汇总：科兴制药2025年第二次临时股东会审议通过H股发行等相关议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900000574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239","HEXmain"],"gpt_icon":0},{"id":"2576059946","title":"科兴制药（688136）披露拟发行H股并在港交所上市，10月17日股价下跌4.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576059946","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576059946?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:28","pubTimestamp":1760711294,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，科兴制药报收于37.02元，较前一交易日下跌4.12%，最新总市值为74.51亿元。近日，科兴生物制药股份有限公司召开2025年第二次临时股东会，审议通过了关于公司发行H股股票并在香港联合交易所上市的相关议案。其中，关于发行H股股票并在香港联合交易所上市、转为境外募集股份有限公司等特别决议议案已获出席股东所持表决权三分之二以上通过，其余普通决议议案亦获过半数通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700038502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688136","HEXmain"],"gpt_icon":0},{"id":"2576193084","title":"10月17日科兴制药创60日新低，中航优选领航混合发起A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2576193084","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576193084?lang=zh_cn&edition=full","pubTime":"2025-10-17 16:16","pubTimestamp":1760688979,"startTime":"0","endTime":"0","summary":"证券之星消息，10月17日科兴制药创60日新低，收盘报37.02元，当日跌4.12%，换手率1.76%，成交量3.54万手，成交额1.35亿元。重仓科兴制药的公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为中航基金的中航优选领航混合发起A。中航优选领航混合发起A目前规模为0.58亿元，最新净值1.8436，较上一交易日上涨1.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700024760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2574450940","title":"每周股票复盘：科兴制药（688136）拟发行H股募资研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2574450940","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574450940?lang=zh_cn&edition=full","pubTime":"2025-10-12 02:37","pubTimestamp":1760207831,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，科兴制药报收于39.6元，较上周的39.02元上涨1.49%。本周，科兴制药10月9日盘中最高价报39.95元。本周关注点公司公告汇总：科兴制药拟发行H股并在港交所上市，募资用于药物研发及海外平台建设。公司公告汇总：公司已累计回购股份1,269,333股，占总股本0.63%，支付资金4,738.19万元。本次发行不超过发行后总股本的15%，并授予超额配售权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2574750169","title":"科兴制药（688136）披露拟发行H股并在港交所上市，10月9日股价下跌0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574750169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574750169?lang=zh_cn&edition=full","pubTime":"2025-10-09 22:59","pubTimestamp":1760021952,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，科兴制药报收于38.81元，较前一交易日下跌0.54%，最新总市值为78.11亿元。该股当日开盘39.02元，最高39.95元，最低38.66元，成交额达9878.73万元，换手率为1.26%。近日，科兴生物制药股份有限公司发布2025年第二次临时股东会会议资料，宣布拟发行H股股票并在香港联合交易所主板上市。本次发行不超过发行后总股本的15%，并授予超额配售权。授权董事会全权处理发行上市相关事宜，决议有效期18个月。上述事项尚需股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900034902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239","HEXmain"],"gpt_icon":0},{"id":"2571534633","title":"科兴制药(688136.SH)筹划发行H股股票并在香港联交所上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2571534633","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571534633?lang=zh_cn&edition=full","pubTime":"2025-09-30 18:26","pubTimestamp":1759228016,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科兴制药(688136.SH)发布公告，为深化科兴生物制药股份有限公司“创新+国际化”的战略布局，加快海外业务发展，进一步提高公司综合竞争力及国际品牌形象，同时充分借助国际资本市场的资源与机制优势，优化资本结构，拓宽多元融资渠道，公司拟发行H股股票并在香港联合交易所有限公司(简称“香港联交所”)主板挂牌上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科兴制药(688136.SH)筹划发行H股股票并在香港联交所上市","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2571120386","title":"科兴制药(688136.SH)：GB10注射液临床试验注册申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2571120386","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571120386?lang=zh_cn&edition=full","pubTime":"2025-09-29 17:38","pubTimestamp":1759138705,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科兴制药(688136.SH)发布公告，近日，公司全资子公司深圳科兴药业有限公司(简称“深圳科兴”)收到国家药品监督管理局(简称“国家药监局”)行政许可文书《受理通知书》，公司申报的“GB10注射液”临床试验申请已获得受理。此次GB10注射液临床试验申请的受理，是公司创新药研发过程中的重要一步，标志着公司基于自主技术平台的双抗研发战略取得关键进展，若该药品研发未来实现成功上市，能够为满足市场需求提供更加多元的产品，有利于丰富公司产品布局，进一步提高公司市场竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688136","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765313418679,"stockEarnings":[{"period":"1week","weight":0.0012},{"period":"1month","weight":-0.1144},{"period":"3month","weight":-0.1923},{"period":"6month","weight":-0.3588},{"period":"1year","weight":0.8761},{"period":"ytd","weight":0.4968}],"compareEarnings":[{"period":"1week","weight":0.003},{"period":"1month","weight":-0.022},{"period":"3month","weight":0.0255},{"period":"6month","weight":0.149},{"period":"1year","weight":0.149},{"period":"ytd","weight":0.1664}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"科兴生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"11768人(较上一季度增加25.03%)","perCapita":"17102股","listingDate":"2020-12-14","address":"山东省济南市章丘区埠村街道创业路2666号","registeredCapital":"20125万元","survey":" 科兴生物制药股份有限公司的主营业务是重组蛋白药物和微生态制剂的研发、生产、销售。公司的主要产品是依普定、赛若金、白特喜、常乐康。","listedPrice":22.33},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科兴制药(688136)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科兴制药(688136)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科兴制药,688136,科兴制药股票,科兴制药股票老虎,科兴制药股票老虎国际,科兴制药行情,科兴制药股票行情,科兴制药股价,科兴制药股市,科兴制药股票价格,科兴制药股票交易,科兴制药股票购买,科兴制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科兴制药(688136)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科兴制药(688136)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}